Cargando…
Histone deacetylases in hearing loss: Current perspectives for therapy
Hearing loss is one of the most frequent health issues in industrialized countries. The pathogenesis and molecular mechanisms of hearing loss are still unclear. Histone deacetylases (HDACs) are emerging as key enzymes in many physiological processes, including chromatin remodeling, regulation of tra...
Autores principales: | Chen, Daishi, Xu, Ming, Wu, Beibei, Chen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese PLA General Hospital
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963466/ https://www.ncbi.nlm.nih.gov/pubmed/29937837 http://dx.doi.org/10.1016/j.joto.2017.04.002 |
Ejemplares similares
-
Preventing ototoxic hearing loss by inhibiting histone deacetylases
por: Layman, W S, et al.
Publicado: (2015) -
Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression
por: Wang, Jie, et al.
Publicado: (2021) -
Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011) -
Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease
por: Wang, Zi-Ying, et al.
Publicado: (2015) -
The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)